catechin has been researched along with Fibrosarcoma in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kalinovsky, T; Monterrey, J; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
Behr, B; Chromik, AM; Daigeler, A; Goertz, O; Harati, K; Hirsch, T; Kapalschinski, N; Klein-Hitpass, L; Kolbenschlag, J; Lehnhardt, M; Slodnik, P; Uhl, W | 1 |
Becerikli, M; Behr, B; Daigeler, A; Harati, A; Harati, K; Hirsch, T; Jacobsen, F; Lehnhardt, M; Renner, M; Wallner, C | 1 |
Han, DW; Hyon, SH; Lee, MH; Park, JC | 1 |
Dell'Aica, I; Donà, M; Garbisa, S; Pezzato, E; Sartor, L | 1 |
Hashimoto-Ohta, A; Isemura, M; Maeda-Yamamoto, M; Miyase, T; Sano, M; Sawai, Y; Suzuki, N | 1 |
Ahn, BW; Ahn, SJ; Hwang, YS; Jeong, M; Jung, MA; Jung, YD; Kim, MH; Kim, SM; Shin, BA | 1 |
Elangovan, V; Govindasamy, S; Sekar, N | 1 |
Nair, SC; Panikkar, B; Panikkar, KR; Varghese, CD | 1 |
Hayakawa, S; Isemura, M; Kimura, T; Minami, T; Saeki, K; Sazuka, M; Shoji, Y | 1 |
Hara, Y; Isemura, M; Kawahara, H; Maeda-Yamamoto, M; Tahara, N; Tsuji, K | 1 |
11 other study(ies) available for catechin and Fibrosarcoma
Article | Year |
---|---|
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Carcinogens; Catechin; Cell Line, Tumor; Chondrosarcoma; Dactinomycin; Dexamethasone; Doxycycline; Fibrosarcoma; Humans; Interleukin-1beta; Lipopolysaccharides; Liposarcoma; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Sarcoma; Sarcoma, Synovial; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Necrosis Factor-alpha | 2013 |
Pro‑apoptotic effects of pycnogenol on HT1080 human fibrosarcoma cells.
Topics: Adult; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Fibrosarcoma; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; Male; Molecular Sequence Data; Plant Extracts; Quercetin; Signal Transduction; Young Adult | 2015 |
Anti‑proliferative activity of epigallocatechin‑3‑gallate and silibinin on soft tissue sarcoma cells.
Topics: Antineoplastic Agents; Antioxidants; Catechin; Cell Line, Tumor; Cell Proliferation; Fibrosarcoma; Humans; Liposarcoma; Sarcoma; Sarcoma, Synovial; Silybin; Silymarin | 2017 |
Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
Topics: Active Transport, Cell Nucleus; Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Caspases; Catechin; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Nucleus; Fibrosarcoma; Gene Expression; Humans; NF-kappa B; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Tumor Suppressor Protein p53 | 2011 |
(-)Epigallocatechin-3-gallate directly inhibits MT1-MMP activity, leading to accumulation of nonactivated MMP-2 at the cell surface.
Topics: Catechin; Cell Membrane; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fibrosarcoma; Flow Cytometry; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Microscopy, Confocal; Protease Inhibitors; Tumor Cells, Cultured | 2002 |
Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
Topics: Camellia sinensis; Catechin; Enzyme Inhibitors; Fibrosarcoma; Gene Expression Regulation, Enzymologic; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Plant Leaves; RNA, Messenger; Tea; Tumor Cells, Cultured | 2003 |
Regulation of urokinase plasminogen activator by epigallocatechin-3-gallate in human fibrosarcoma cells.
Topics: Antineoplastic Agents, Phytogenic; Blotting, Northern; Blotting, Western; Catechin; Chloramphenicol O-Acetyltransferase; Fibrosarcoma; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Indicators and Reagents; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Phosphorylation; RNA, Messenger; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2004 |
Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis.
Topics: Animals; Catechin; Diet; Fibrosarcoma; Flavonoids; Incidence; Luteolin; Male; Methylcholanthrene; Mice; Mice, Inbred Strains; Quercetin; Rutin; Skin Neoplasms | 1994 |
Effect of asoka on the intracellular glutathione levels and skin tumour promotion in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Catechin; Croton Oil; Drug Screening Assays, Antitumor; Fibrosarcoma; Glutathione Reductase; Glutathione Transferase; Male; Methylcholanthrene; Mice; Papilloma; Sarcoma 180; Skin Neoplasms | 1993 |
Inhibition of matrix metalloproteinases by tea catechins and related polyphenols.
Topics: Biflavonoids; Catechin; Cell Line; Fibrosarcoma; Flavonoids; Gallic Acid; Gene Expression Regulation; Humans; Metalloendopeptidases; Neoplasm Invasiveness; Phenols; Polymers; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship; Tea; Transcription, Genetic; Tumor Cells, Cultured | 1999 |
Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells.
Topics: Antioxidants; Biflavonoids; Catechin; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Fibrosarcoma; Humans; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Neoplasm Invasiveness; Tea; Tumor Cells, Cultured; Umbilical Veins | 1999 |